Ryght AI Welcomes West Virginia University Into Its Global Site Research Network

Ryght, a leader in real-time generative AI healthcare technology for clinical research, announced today that the West Virginia University (WVU) Cancer Institute has joined its distinctive Ryght Research Network. This global network, which features an AI digital twin of every research site worldwide, now also includes prestigious academic institutions like WVU that are using Ryght’s AI platform and applications to streamline workflows and revolutionize clinical trial processes.

As a member of the Ryght Research Network, WVU will have access to state-of-the-art AI technologies, tools, and resources, as well as opportunities for collaboration with other leading institutions dedicated to advancing clinical research through AI solutions. This partnership will foster interdisciplinary research and innovation, allowing WVU researchers to explore new frontiers in AI and develop clinical trial solutions that rapidly expand access to every patient in the state.

“We are excited to join the Ryght Research Network and to bring AI solutions to our physicians, researchers, trialists, and patients,” said Hannah Hazard-Jenkins, MD, Executive Chair and Director of the WVU Cancer Institute and Professor of Surgery. “As an institution, we have always been committed to assuring our patients get access to innovative studies and life-saving therapies. Through this partnership with Ryght AI, we are destined to exactly achieve that.”

The Ryght Research Network leverages advanced generative AI capabilities to process site-specific and industry-wide data, delivering real-time insights that enable sponsors and CROs to identify, select and activate the best sites for their trials, while empowering sites to make data-driven decisions to run the very best studies for their patients. By automating crucial tasks such as site selection, feasibility assessment, patient pre-screening and study compliance, the network transforms traditional trial workflows into automated communication between sponsors and sites, while simplifying trial management and accelerated patient selection for all parties.

Through this partnership, WVU aims to foster a culture of innovation and collaboration, and to continue being a pioneer in cutting-edge research. The university will also work closely with industry partners to translate AI research into practical applications that benefit the community at large.

“We are delighted to partner with physicians, researchers, and staff at WVU and to bring generative AI solutions to their clinical trial operations and research program,” said Chadi Nabhan, MD, MBA, FACP, Chief Medical Officer and Head of Strategy at Ryght. “Our mission and that of WVU are aligned on bringing evolving AI technologies to improve clinical trials’ access to every patient. “Together, we hope to improve the outcomes of all patients impacted with cancer.”

About Ryght:

Ryght AI is transforming clinical research with a cutting-edge platform that includes an AI digital twin of every research site across the globe. This innovative approach empowers sponsors and CROs to significantly accelerate clinical trial study startup through faster site selection and streamlined feasibility workflows, all powered by advanced generative and agentic AI. Furthermore, Ryght’s SOC Type 2-compliant platform enhances efficiency by fostering seamless, real-time communication between sponsors, CROs, and research sites. The company is backed by leading investors including Foothill Ventures, AIX Ventures, Virtue Ventures, IASO Ventures, Top Harvest Capital, and Page One Ventures.

For more information, please visit www.ryght.ai. To discuss AI-powered clinical trial solutions or network membership for your site, CRO or biopharma company, please email sales@ryght.ai.

About West Virginia University Cancer Institute:

The WVU Cancer Institute is committed to providing high-quality cancer care and leading-edge research to patients in West Virginia and beyond. Through collaborations with top researchers and clinicians, the WVU Cancer Institute aims to translate groundbreaking discoveries into effective cancer therapies. Additionally, by offering a network of sites around the state, the WVU Cancer Institute has made cancer care close to home a priority and more accessible than ever. For more information, visit WVUMedicine.org/Cancer.

Contact Information

Riley Munks

PR Advisor

Activate PR - https://www.activate-pr.com/

riley@activate-pr.com